Nouraee Nazila, Calin George A
Department of Experimental Therapeutics, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA.
Microrna. 2013;2(2):102-17. doi: 10.2174/22115366113029990015.
MicroRNAs (miRNAs) are attractive, short, non-coding RNAs widely studied for their fundamental roles in tissue homeostasis, cell proliferation, and dysregulation in cancer. A vast majority of investigations and technical improvements have focused on miRNAs' tumor-specific expression patterns, which provide novel molecular biomarkers for cancer detection and targeted therapies. In this review, we focus on recent achievements in biomarker validation and potential for cancer treatment, with special trend in non-invasive strategies to evaluate miRNAs, especially for diagnostic and prognostic applications. We further include a large compilation of PubMed data regarding microRNAs reported as diagnostic or prognostic cancer biomarkers in at least three studies.
微小RNA(miRNA)是一类引人关注的短链非编码RNA,因其在组织稳态、细胞增殖及癌症失调中的重要作用而被广泛研究。绝大多数研究和技术改进都聚焦于miRNA的肿瘤特异性表达模式,这些模式为癌症检测和靶向治疗提供了新的分子生物标志物。在本综述中,我们重点关注生物标志物验证方面的最新成果以及癌症治疗潜力,特别是在评估miRNA的非侵入性策略方面的特殊趋势,尤其是用于诊断和预后应用。我们还进一步汇总了大量来自至少三项研究中报道的将miRNA作为癌症诊断或预后生物标志物的PubMed数据。